CLINICAL HISTORY
Patient: 48-year-old white male.
Chief Complaint: Fever and chills, dyspnea, and productive cough.
History of Present Illness:
The patient was symptomatic for 2 weeks prior to admission and unresponsive to outpatient treatments. The only positive finding on physical examination was a high oral temperature (38°C). Positive laboratory findings at the time of admission include macrocytic anemia (Hb: 11 g/dL, MCV:110 fl) associated with leucopenia and thrombocytopenia, raised ESR, positive CRP, and most notably, hyperphosphatemia (14.7 mg/dL; reference range: 2.5-5.0 mg/dL) accompanied with normal serum calcium, PTH, and mildly disturbed renal function tests ( Table 1) . Chest X-ray and spiral CT scan showed consolidation of the anterior segment of the right upper lobe of the lung ( Figure 1 ).
The pneumonia was successfully treated with the antibiotic regimen consisting of ceftazidime, clindamycin, and erythromycin.
Because of intractable pancytopenia, the patient underwent a bone-marrow aspiration biopsy that showed increased plasma cells consistent with plasma-cell dyscrasia ( Figure 2) ; immunohistochemical staining of the biopsy specimen revealed λ light chain restriction ( Figure 3 ). Serum total protein and IgG were significantly raised, while IgM and IgA levels were low. The serum β2 -microglobulin level was high, and the urine was positive for Bence-Jones protein. Serum protein electrophoresis (SPE) revealed an M-spike in the gamma-region of the gel (Figure 4) .
Keywords: plasma cell dyscrasia, multiple myeloma, pseudohyperphosphatemia, hyperglobulinemia 3. Hyperimmuneglobulinemia, hyperlipidemia, hyperbilirubinemia, and in vitro hemolysis can cause a pseudohyperphosphatemia 3-8 as explained below.
4. The usual colorimetric method for the measureing inorganic phosphate is based on the addition of phosphomolybdic acid to the specimen; its reduction causes a color change that is measured spectrophotometrically. 5, 6 Turbidity in hyperproteinemic specimens can result in falsely high absorbance. 7 Hyperproteinemia is not always associated with pseudohyperphosphatemia, suggesting that both the physicochemical properties and the quantity of protein are important factors. 3 Pseudohyperphosphatemia in multiple myeloma, for example, may be due to the presence of phosphate binding globulin. 9 Interestingly, pseudohyperphosphatemia may occur intermittently in spite of similar levels of abnormal immunoglobulin.
5. Analytical methods that separate proteins from serum before measuring inorganic phosphorus are not susceptible to the interference from turbidity in hyperproteinemic specimens. However, methods that rely on diluting serum proteins prior to measurement of phosphate are vulnerable to falsely elevated phosphate results because the dilution may not be adequate in severe hyperglobulinemia.
Use of a purine nucleoside phosphorylase-based enzymatic method, followed by converting the phosphomolybdate complex to a heteropolymolybdate may also eliminate the protein interference. Accurate measurements of phosphate can also be obtained with the phosphomolybdate calorimetric assay after appropriate chemotherapeutic regimen. 
Figure 3
Immunohistochemical study of Bone marrow biopsy showing diffuse staining for λ light chain.
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